Item 2.02 Results of Operations and Financial Condition.

On May 12, 2020, Surface Oncology, Inc. (the "Company") announced Financial Results and Corporate Highlights for the three months ended March 31, 2020. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K.

The information in this Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



   Exhibit
   Number                               Description

   99.1        Press release issued by Surface Oncology, Inc. on May 12, 2020




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses